How to overcome resistance of influenza A viruses against adamantane derivatives

Antiviral Research

Volumn 37, Issue 2, 1998, Pages 83-95

  Scholtissek, C ^a   Quack, G ^b   Klenk, H D ^c   Webster, R G ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b MERZ PHARMACEUTICALS GMBH   (Germany)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADAMANTANE DERIVATIVE; AMANTADINE; HEMAGGLUTININ; ION CHANNEL; MEMANTINE; VIRUS PROTEIN;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG SENSITIZATION; DRUG STRUCTURE; INFLUENZA VIRUS A; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; VIRUS INHIBITION; VIRUS MUTATION; VIRUS REPLICATION;

ADAMANTANE; ANIMALS; ANTIVIRAL AGENTS; CELL LINE; CHICK EMBRYO; DOGS; DRUG RESISTANCE, MICROBIAL; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HEMOLYSIS; HUMANS; HYDROGEN-ION CONCENTRATION; INFLUENZA A VIRUS; MOLECULAR STRUCTURE; VARIATION (GENETICS); VIRAL MATRIX PROTEINS; VIRUS REPLICATION;

ANIMALIA; INFLUENZA A VIRUS; INFLUENZA VIRUS; RNA VIRUSES;

EID: 0032005664     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(97)00061-2     Document Type: Article

References (32)

1. Appleyard, G., 1977. Amantadine-resistance as genetic marker for influenza viruses. J. Gen. Virol. 36, 249-255.
2. Appleyard, G., Marber, H.B., 1974. Plaque formation by influenza viruses in the presence of trypsin. J. Gen. Virol. 25, 351-357.
3. Appleyard, G., Marber, H.B., 1975. A plaque assay for the study of influenza virus inhibitors. J. Antimicrob. Chemother. 1, 49-53.
4. Bean, W.J., Sriram, G., Webster, R.G., 1980. Electrophoretic analysis of iodine-labeled influenza virus RNA segments. Ann. Biochem. 102, 228-232.
5. Bean, W.J., Threlkeld, S.C., Webster, R.G., 1989. Biological potential for amantadine-resistant influenza A virus in an avian model. J. Infect. Dis. 159, 1050-1056.
6. Bormann, J., Gold, M., Schatton, W., 1990. Substituted adamantane derivatives for prevention and treatment of cerebral ischemia, EP. 392059-A, 90, 10-17.
7. Cochran, K.W., Maassab, H.R., Tsunoda, A., Berlin, B.S., 1965. Studies of the antiviral activity of amantadine hydrochloride. Ann. NewYork Acad. Sci. 130, 432-439.
8. Daniels, R.S., Downie, J.C., Hay, A.J., Knossow, M., Skehel, J.J., Wang, M.L., Wiley, D.C., 1985. Fusion mutants of the influenza virus hemagglutinin glycoprotein. Cell 40, 431-439.
9. Danysz, W., Parsons, C.G., Kronhuber, J., Schmidt, W.J., Quack, G., 1997. Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents - Preclinical studies. Neurosci. Biobehav. Rev. 21, 455-468.
10. Davies, W.L., Grunert, R.R., Haff, R.F., McGahen, J.W., Neumayer, E.M., Paulshok, M., Watts, J.C., Wood, T.R., Herrmann, B.C., Hoffmann, C.E., 1964. Antiviral activity of 1-adamantanamine (amantadine). Science 144, 862-863.
11. Duff, K.C., Ashley, R.H., 1992. The transmembrane domain of influenza A. M2 protein forms amantadine-sensitive protein channels in planar lipid bilayers. Virology 190, 485-489.
12. Hay, A.J., Wolstenholm, A.J., Skehel, J.J., Smith, M.H., 1985. The molecular basis of the specific anti-influenza action of amantadine. EMBO J. 4, 3021-3024.
13. Huang, R.T.C., Rott, R., Klenk, H.-D., 1981. Influenza viruses cause hemolysis and fusion of cells. Virology 110, 243-247.
14. Indulen, M.K., Polis, J.J., Kalnina, V.A., Ryasantzeva, G.M., Dsegudse, D.R., Eglite, F.E., Zamyatina, N.A., Kanninokova, N.A., Feldblum, F.L., 1979a. Antiviral activity of new amantadine derivatives. In: Kukaine, R.A., Muszenieze, A.J., Indulen, M.K., Duk, A.E. (Eds.), Antiviral Activity and Mode of Action of Chemical Compounds. Sinatne, Riga (in Russian), pp. 41-48.
15. Indulen, M.K., Polis, J.J., Kanele, I.A., Ryasantzeva, G.M., Dsegudse, D.R., Kalnina, V.A., Grabe, I.J., 1979b. Antiviral activity of a series of rimantadine derivatives. In: Kukaine, R.A., Muszenieze, A.J., Indulen, M.K., Duk, A.E. (Eds.), Antiviral Activity and Mode of Action of Chemical Compounds. Sinatne, Riga (in Russian), pp. 34-40.
16. Kato, N., Eggers, H.J., 1969. Inhibition of uncoating of fowl plague virus by 1-adamantane-amine hydrochloride. Virology 37, 632-641.
17. Katz, J.M., Wang, M., Webster, R.G., 1990. Direct sequencing of the HA gene of influenza (H3N2) virus in original clinical samples reveals sequence identity with mammalian cell-grown virus. J. Virol. 64, 1808-1811.
18. Kolocouris, N., Foskolos, G.B., Kolocouris, A., Marakos, P., Pouli, N., Fytas, G., Ikeda, S., De Clercq, E., 1994. Synthesis and antiviral activity evaluation of some aminoadamantane derivatives. J. Med. Chem. 37, 2896-2902.
19. Kolocouris, N., Kolocouris, A., Foscolos, G.B., Fytas, G., Neyts, J., Padalko, E., Balzarini, J., Snoeck, R., Andrei, G., De Clercq, E., 1996. Synthesis and antiviral activity evaluation of some new aminoadamantane derivatives 2. J. Med. Chem. 39, 3307-3318.
20. Lin, T-I., Heider, H., Schroeder, C., 1997. Different modes of inhibition by adamantane amine derivatives and natural polyamines of the functionally reconstituted influenza virus M2 proton channel protein. J. Gen. Virol. 78, 767-774.
21. Ohkuma, S., Poole, B., 1978. Fluorescence probe measurement of the intralysosomal pH in living cells and perturbation of pH by various agents. Proc. Natl. Acad. Sci. USA 75, 3327-3331.
22. Pinto, L.H., Holsinger, L.J., Lamb, R.A., 1992. Influenza virus M2 protein has ion channel activity. Cell 69, 517-528.
23. Sanger, F., Nicklen, S., Coulson, A.-R., 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74, 5463-5467.
24. Schäfer, J.R., Kawaoka, Y., Bean, W.J., Süss, J., Senne, D., Webster, R.G., 1993. Origin of the pandemic 1957 H2 influenza A virus and the persistence of its possible progenitors in the avian reservoir. Virology 194, 781-788.
25. Schlegel, H., Dickson, R.B., Willingham, M.C., Pastan, I.H., 1982. Amantadine and dansylcadavarine inhibit vesicular stomatitis virus uptake and receptor-mediated endocytosis of α-macroglobulin. Proc. Natl. Acad. Sci. USA 79, 2291-2295.
26. Schroeder, C., Ford, C.-M., Wharton, S.-A., Hay, A.J., 1994. Functional reconstitution in lipid vesicles of influenza virus M2 protein expressed by baculovirus: Evidence for proton transfer activity. J. Gen. Virol. 75, 3477-3484.
27. Sansom, M.S., Kerr, I.D., 1993. Influenza virus M2 protein: A molecular modelling study of the ion channel. Protein Eng. 6, 65-74.
28. Steinhauer, D.A., Wharton, S.W., Skehel, J.J., Wiley, D.C., Hay, A.J., 1991. Amantadine selection of a mutant influenza virus containing an acid-stable hemagglutinin glycoprotein: Evidence for virus-specific regulation of the pH of glycoprotein transport vesicles. Proc. Natl. Acad. Sci. USA 88, 11525-11529.
29. Sugrue, R.J., Hay, A.J., 1991. Structural characteristics of the M2 protein of influenza A viruses: Evidence that it forms a tetrameric channel. Virology 180, 617-624.
30. Tu, Q., Pinto, L.H., Guangxiang, L., Shaughnessy, M.A., Mullaney, D., Kurtz, S., Krystal, M., Lamb, R.A., 1996. Characterization of inhibition of M2 ion channel activity by BL-1743, an inhibitor of influenza A virus. J. Virol. 70, 4246-4252.
31. von Itzstein, M., Wu, W.-Y., Kok, G.B., Pegg, M.S., Dyason, J.C., Jin, B., Van Phan, T., Smythe, M.L., White, H.F., Oliver, S.W., Colman, P.M., Varghese, J.N., Ryan, D.M., Woods, J.M., Bethell, R.C., Hotham, V.J., Cameron, J.M., Penn, C.R., 1993. Rational design of potent sialidase-based inhibitors of influenza virus protections. Nature 363, 418-423.
32. Zebedee, S., Lamb, R.A., 1989. Nucleotide sequences of influenza A virus RNA segment 7: A comparison of five isolates. Nucleic Acids Res. 7, 2870.